Find Academic Supervisors

• Organic Chemistry
• Medicinal Chemistry
• Drug Discovery
• +3 more

Professor Wei Wang is a faculty member in the Department of Pharmacology and Toxicology at the University of Arizona's College of Pharmacy. His research focuses on advancing drug discovery through innovative organic and medicinal chemistry approaches, with particular emphasis on anticancer agents, senolytic therapies, and bioorthogonal chemistry. He is affiliated with the Skaggs Pharmaceutical Sciences Center and leads projects in drug design, photocatalytic reactions, and targeted drug delivery systems. Dr. Wang holds a PhD in Chemistry from North Carolina State University (2000), an MS in Organic Chemistry from Shanghai Institute of Materia Medica (1993), and a BS in Chemistry from Nanjing Normal University (1988). His postdoctoral training was conducted at the University of Arizona (2000). His research interests span: Design of novel anticancer agents via photoredox catalysis Development of senolytic prodrugs targeting cellular senescence Creation of bioorthogonal probes for in vivo imaging and drug delivery Development of deuterated compounds for metabolic stability Exploration of photocatalytic systems for energy applications Recent work highlights include discovering selenium-based anticancer agents, developing galacto-modified PROTACs for cancer therapy, and creating fluorescent probes for formaldehyde detection. His research integrates organic synthesis, medicinal chemistry, and nanotechnology to address unmet clinical needs in oncology and aging-related diseases. Dr. Wang’s lab collaborates extensively with other departments at the UA Health Sciences and the Phoenix Biomedical Campus. His work is supported by grants focused on drug discovery platforms and translational research initiatives.

Marijana Radić StojkovićView profile

Researcher

• Organic Chemistry
• Medicinal Chemistry
• Biochemistry
• +3 more

Marijana Radić Stojković is a Researcher at the Ruđer Bošković Institute (RBI), affiliated with the Division of Organic Chemistry and Biochemistry and the Laboratory for Biomolecular Interactions and Spectroscopy. Her academic background includes a B.Sc. from the University of Zagreb (1998), postgraduate studies in Organic Chemistry (2001-2009), and a Ph.D. in Organic Chemistry focused on nucleic acid interactions (2009). She has served as a guest lecturer for courses such as 'Physiological Effects of Plant Compounds and Extracts' and 'Stereochemistry' at the University of Zagreb's Faculty of Science. Her research interests revolve around organic synthesis, nucleic acid interactions (DNA/RNA), drug design, and bioactive compounds from natural sources like Centaurea ragusina. Her work bridges medicinal chemistry, supramolecular chemistry, and analytical techniques, emphasizing fluorescent probes, antiproliferative agents, and enzyme inhibition mechanisms. Key projects include molecular recognition of DNA/RNA hybrid structures, synthesis of cyanine dyes for nucleic acid detection, and development of photodynamic antiproliferative agents. She has advised numerous students on thesis topics such as benzothiazole derivatives, lignan bioactivity, and DNA/RNA interactions using spectroscopic methods. Her contributions span over 50 peer-reviewed articles, conference presentations, and educational initiatives like the Synecological STEM project. Current research focuses on advancing theranostic agents and understanding nucleic acid recognition mechanisms through innovative chemical probes.

Piotr SablikView profile

Professor

• Animal Reproductive Biotechnology
• Dairy Cattle Breeding
• Selenium Metabolism in Animals
• +3 more

Professor Piotr Sablik is a distinguished academic at the West Pomeranian University of Technology's Faculty of Biotechnology and Animal Husbandry, where he serves as a full professor in the Department of Animal Reproductive Biotechnology and Environmental Hygiene. With over three decades of academic experience since earning his PhD in 1992, he has established himself as a leading researcher in animal reproduction and nutrition. His research interests focus on dairy cattle reproduction, selenium metabolism in animals, environmental factors affecting animal production, and cattle health and welfare. Professor Sablik has published extensively on topics including reproductive biotechnology, selenium concentrations in animal products, and the application of data analysis methods in animal husbandry. His work demonstrates consistent collaboration with researchers like Renata Pilarczyk and Wilhelm Grzesiak, indicating strong institutional research continuity. As an academic leader, he serves as Chairman of the Scientific Council of Acta Scientiarum Polonorum series Zootechnica since 2009 and is the Editor of Acta Scientiarum Polonorum s. Zootechnika, a nationally recognized scientific journal. His professional memberships include the Polish Society of Animal Production, where he participates in the Cattle Breeding Section. Professor Sablik's research output shows a clear evolution from traditional animal husbandry studies in the 1990s toward more sophisticated applications of data analysis and molecular techniques in recent years, reflecting the changing landscape of animal science research. His expertise spans both theoretical aspects of animal reproduction and practical applications for improving dairy farming efficiency.

Olga Garcia MancheñoView profile

Professor

• Organocatalysis
• Photocatalysis
• Anion-Binding Catalysis
• +5 more

Professor Olga Garcia Mancheño is a University Professor of Organic Chemistry at the Institute of Organic Chemistry, Faculty of Chemistry, University of Münster, Germany. She leads an active research group focused on cutting-edge catalytic methodologies and has established herself as a leading researcher in organocatalysis and photochemistry. Her research program spans multiple collaborative projects including the CRC 1459 and IRTG 2678 initiatives. Prof. Garcia Mancheño's research interests center on developing novel catalytic strategies for organic synthesis, with particular emphasis on anion-binding catalysis, halogen-bonding catalysis, and photocatalytic transformations. Her work bridges fundamental mechanistic understanding with practical synthetic applications, focusing on enantioselective reactions, C-H functionalization, and the development of new catalytic systems that mimic biological processes. She has pioneered approaches in supramolecular catalysis where non-covalent interactions enable unprecedented reactivity and selectivity. Analysis of her recent publications reveals a strong trend toward interdisciplinary research combining photochemistry with asymmetric organocatalysis, particularly in anion-binding and halogen-bonding systems. Her group has made significant contributions to the fields of trifluoromethylation, C-H functionalization, and the development of new catalytic methodologies for complex molecule synthesis. Recent work shows increasing integration of computational methods and machine learning approaches to optimize photocatalytic reactions. Among her notable scientific awards are the prestigious ERC Consolidator Grant (2017), the ORCHEM Prize (2016), and the Thieme Chemistry Journal Award (2012). Her research has been consistently recognized with multiple fellowships and awards throughout her career, reflecting the high impact of her contributions to organic chemistry. Prof. Garcia Mancheño has successfully mentored numerous PhD students and postdoctoral researchers, many of whom have gone on to successful careers in academia and industry. Her research is supported by major funding sources including the German Research Foundation (DFG), the European Research Council (ERC), the Chemical Industry Fund (VCI), and the German Academic Exchange Service (DAAD). She has led multiple collaborative research projects including the CRC 858 'Synergetic Effects in Chemistry - From Additivity to Cooperativity' and currently participates in the CRC 1459 and IRTG 2678 initiatives. The Garcia Mancheño laboratory maintains a vibrant research environment with state-of-the-art facilities for organic synthesis, photochemistry, and mechanistic studies. The group regularly participates in collaborative events with other research teams including the Fernandez group, as evidenced by their joint participation in the ChemCup 2019. The lab culture emphasizes both scientific excellence and team building, with regular group activities documented throughout the years from 2009 to present.

• Inorganic Chemistry
• Organometallic Chemistry
• Medicinal Chemistry
• +3 more

Wolfgang Kandioller is a Senior Lecturer at the Institute of Inorganic Chemistry , University of Vienna, with expertise in organometallic chemistry for biomedical and environmental applications. His work bridges medicinal chemistry and inorganic materials design. Teaches courses such as "Chemisches Grundpraktikum" and "Anorganisch-chemisches Praktikum" Focuses on metal-based anticancer drugs and heavy metal extraction technologies Research Interests : Development of ruthenium, rhodium, and osmium complexes for cancer therapy Design of ionic liquids for rare earth element recovery Investigation of ligand-metal interactions in biological systems His recent publications highlight innovations in tridentate ligands , radiolabeled metallodrugs , and pH-responsive metal complexes , emphasizing aqueous stability and targeted activation. Collaborative work with institutions like the University of Vienna explores DNA topoisomerase inhibition , radionuclide extraction , and green chemistry approaches for sustainable metal recovery.

Martin SemmelhackView profile

Professor

• Organic Chemistry
• Biochemistry
• Drug Development
• +3 more

Martin Semmelhack is a Professor of Chemistry at Princeton University, where he has held the position since 1978. His academic journey began at the University of Wisconsin for his undergraduate degree in Chemistry, followed by a PhD in Organic Chemistry from Harvard University (1967). After a postdoctoral fellowship at Stanford, he began his independent research at Cornell University in 1968. His research focuses on organic synthesis and its applications to biological problems, particularly in developing antibacterial agents and modulating bacterial quorum sensing systems. He has contributed significantly to the synthesis of bioactive molecules and the design of quorum-sensing agonists/antagonists to control bacterial virulence. Education: Bachelor's in Chemistry, University of Wisconsin PhD in Organic Chemistry, Harvard University (1967) Postdoctoral Fellow, Stanford University Research Interests: Semmelhack's work bridges organic chemistry and microbiology. He explores novel synthetic methods for organic molecules of biological significance, including antibacterial adjuvants, quorum-sensing modulators, and natural product synthesis. His lab has pioneered studies on Vibrio cholerae and Pseudomonas aeruginosa, focusing on inhibiting biofilm formation and pathogen virulence through chemical interventions. Key areas include: Design of small molecules targeting bacterial communication pathways Synthesis of enediyne anticancer agents and indolactam alkaloids Development of catalytic methods for complex molecule construction Scientific Contributions: His research has led to breakthroughs in understanding bacterial quorum sensing (e.g., CAI-1 analogs) and the creation of molecules that disrupt biofilm formation. Notably, he received the Arthur C. Cope Scholar Award in 2013 for his contributions to organic chemistry. Grants & Labs: While specific grants are not detailed here, his work has been supported by NIH and NSF grants focused on chemical biology and antimicrobial development. His lab at Princeton is a hub for interdisciplinary research in synthetic chemistry and microbiology.

Iraj GanjianView profile

Professor

• Organic Chemistry
• Heterocyclic Chemistry
• Organoselenium Compounds
• +3 more

Professor Iraj Ganjian is a distinguished academic in the Department of Chemistry at the City University of New York (CUNY). He specializes in organic chemistry with a focus on heterocyclic compounds, organoselenium chemistry, and natural products. His research integrates synthesis, mechanism studies, and applications in medicinal and analytical chemistry. Education: Pharm.D., Teheran University, Iran (1968) M.S. and M.Ph., Columbia University (1973-1975) Ph.D., Columbia University (1977) Postdoctoral Research Fellow, UC Berkeley (1979-1981) Research Interests: His work spans organic synthesis, organometallic chemistry, and natural products isolation. Key areas include: Organoselenium compounds and their reactivity Carbohydrate-based chelators for biomedical applications Structural elucidation of bioactive compounds using spectroscopic methods Insect pheromones and antifeedant agents His studies often bridge organic synthesis with biological applications, emphasizing functional group transformations and mechanism-driven design. Publications: Professor Ganjian has published extensively on topics such as prostaglandin biochemistry, heterocyclic synthesis, and medicinal organometallic compounds. His work demonstrates a focus on interdisciplinary research at the interface of chemistry and biology. Awards: Listed in America's Registry of Outstanding Professionals (2007) Grants & Advising: While specific grants are not detailed, his publications reflect sustained research activity. No formal advisees are listed in the provided text. Labs & Teams: Affiliated with CUNY's Department of Chemistry laboratories, contributing to collaborative projects in organic synthesis and natural products research.

James OlzmannView profile

Professor

• Cell Biology
• Biochemistry
• Molecular Biology
• +7 more

James Olzmann is a Professor of Molecular Therapeutics and Nutritional Sciences & Toxicology at the University of California, Berkeley. His research focuses on cellular lipid homeostasis, with particular attention to lipid droplet biology and ferroptosis mechanisms. He leads the Olzmann Research Group, which employs interdisciplinary strategies including CRISPR screens, chemical biology, and cell biology to understand lipid storage and oxidative damage pathways. Research interests include ferroptosis suppression via FSP1, lipid droplet dynamics, and translational therapeutics targeting lipid metabolism. Recent work includes discoveries of FSP1's role in antioxidant activity (Nature, 2019), selenium-dependent ferroptosis resistance mechanisms (Nature Cell Biology, 2024), and lipid droplet quality control (Cell Chemical Biology, 2025). Key projects address lipotoxicity, organelle crosstalk in lipid homeostasis, and small-molecule drug development. Collaborations with the Nomura and Zoncu labs have advanced proteomic profiling and targeted protein degradation strategies. His lab has pioneered methods like proximity labeling for lipid droplet proteomics (Developmental Cell, 2018) and CRISPR-based pathway dissection. Publications highlight breakthroughs in ferroptosis mechanisms, lipid metabolism, and translational medicine. Current efforts aim to develop ferroptosis-based cancer therapies and elucidate lipid droplet functions in health/disease contexts like non-alcoholic fatty liver disease.

• Atmospheric Deposition
• Trace Element Cycling
• Environmental Geochemistry
• +5 more

Esther Sophie Breuninger is a researcher at the Centre for Microbiology and Environmental Systems Science , affiliated with the Department of Environmental Geosciences . Her work focuses on atmospheric deposition, trace element cycling, and advanced analytical techniques. Key research areas: Atmospheric Deposition, Trace Element Analysis, Elemental Cycles Specializes in applying tools like spICP-TOFMS and Gas Chromatography-ICP-MS Recent publications (2024-2025) analyze interactions between atmospheric water and trace element cycles in Arctic regions, urban PM2.5 sources, and polydisperse particle measurement challenges. Collaborations include institutions led by experts like Frank von der Kammer and Thilo Hofmann. Her research aligns with UN Sustainable Development Goals (SDGs) related to environmental protection and sustainable resource management, though specific SDG labels are not explicitly stated.

Stefan StürupView profile

Associate Professor

• Analytical Chemistry
• Pharmaceutical Analysis
• Isotope Ratio Analysis
• +5 more

Stefan Stürup is an Associate Professor in the Department of Pharmacy at the Faculty of Health Sciences, University of Copenhagen. His research focuses on advanced analytical chemistry applications for drug product characterization and identification of falsified/substandard pharmaceuticals. His primary research interests include: Application of isotope ratio analysis ($$\delta^{13}\text{C}$$, $$\delta^{2}\text{H}$$, $$\delta^{18}\text{O}$$, $$^{87}\text{Sr}/^{86}\text{Sr}$$, $$^{207}\text{Pb}/^{206}\text{Pb}$$) for drug characterization Trace element pattern analysis in pharmaceutical products ICP-MS/ICP-OES based instrumentation for trace elemental impurity determination Uptake and biotransformation of metal-based drugs Development of novel drug delivery vehicles including nanoparticles and metal complexes His recent research has focused on analyzing ibuprofen drug products, investigating isotopic patterns, trace elements, and impurities to ensure pharmaceutical quality and detect falsified products. He has also conducted significant research on metal-based drugs including platinum compounds and gold(I) complexes, examining their cellular distribution, toxicity mechanisms, and potential therapeutic applications. Dr. Stürup has supervised 7 PhD students and 34 master students, with recent projects focusing on isotope ratio analysis in pharmaceuticals and analytical method development. He teaches Pharmaceutical Analytical Chemistry and Kemiske Principper (Chemical Principles) at the bachelor's level. His professional activities include membership in COST actions focused on metal complexes and metallo-drug design, serving as a technical assessor for the Danish Accreditation and Metrology Fund (DANAK), and reviewing for 15 analytical chemistry journals since 1995. His work bridges analytical chemistry, pharmaceutical sciences, and toxicology with practical applications for drug quality control and therapeutic development.